MAI Capital Management - Astellas Pharma Inc ownership

Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 13 filers reported holding Astellas Pharma Inc in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MAI Capital Management ownership history of Astellas Pharma Inc
ValueSharesWeighting
Q3 2023$264,362
+58.5%
19,087
+70.1%
0.00%
+100.0%
Q2 2023$166,834
+5.6%
11,221
+6.5%
0.00%
-75.0%
Q1 2019$158,000
+4.6%
10,534
-11.1%
0.01%
-11.1%
Q4 2018$151,000
-27.1%
11,8530.0%0.01%
-18.2%
Q3 2018$207,000
+3.5%
11,853
-9.7%
0.01%0.0%
Q2 2018$200,000
+0.5%
13,1260.0%0.01%0.0%
Q1 2018$199,000
+19.2%
13,1260.0%0.01%
+22.2%
Q4 2017$167,00013,1260.01%
Other shareholders
Astellas Pharma Inc shareholders Q1 2018
NameSharesValueWeighting ↓
THOMAS WHITE INTERNATIONAL LTD 659,892$10,254,0001.47%
TODD ASSET MANAGEMENT LLC 963,505$15,048,0000.46%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 694,200$10,843,0000.14%
SCOUT INVESTMENTS, INC. 179,686$2,792,0000.08%
Boston Common Asset Management, LLC 60,610$942,0000.05%
L & S Advisors Inc 10,000$156,0000.04%
QUADRANT CAPITAL GROUP LLC 3,443$49,0000.03%
PARAMETRIC PORTFOLIO ASSOCIATES LLC 1,012,486$15,815,0000.02%
OLD NATIONAL BANCORP /IN/ 12,094$188,0000.01%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 181,668$2,838,0000.01%
View complete list of Astellas Pharma Inc shareholders